1. Home
  2. LEXX vs BWEN Comparison

LEXX vs BWEN Comparison

Compare LEXX & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • BWEN
  • Stock Information
  • Founded
  • LEXX 2004
  • BWEN N/A
  • Country
  • LEXX Canada
  • BWEN United States
  • Employees
  • LEXX N/A
  • BWEN N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • LEXX Health Care
  • BWEN Industrials
  • Exchange
  • LEXX Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • LEXX 19.6M
  • BWEN 41.1M
  • IPO Year
  • LEXX N/A
  • BWEN N/A
  • Fundamental
  • Price
  • LEXX $0.82
  • BWEN $2.22
  • Analyst Decision
  • LEXX Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • LEXX 1
  • BWEN 3
  • Target Price
  • LEXX $5.00
  • BWEN $4.50
  • AVG Volume (30 Days)
  • LEXX 89.7K
  • BWEN 129.1K
  • Earning Date
  • LEXX 07-14-2025
  • BWEN 08-12-2025
  • Dividend Yield
  • LEXX N/A
  • BWEN N/A
  • EPS Growth
  • LEXX N/A
  • BWEN N/A
  • EPS
  • LEXX N/A
  • BWEN N/A
  • Revenue
  • LEXX $615,923.00
  • BWEN $142,358,000.00
  • Revenue This Year
  • LEXX $6.04
  • BWEN $7.86
  • Revenue Next Year
  • LEXX $8.36
  • BWEN $4.51
  • P/E Ratio
  • LEXX N/A
  • BWEN N/A
  • Revenue Growth
  • LEXX 49.85
  • BWEN N/A
  • 52 Week Low
  • LEXX $0.81
  • BWEN $1.41
  • 52 Week High
  • LEXX $4.38
  • BWEN $3.69
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 32.80
  • BWEN 64.21
  • Support Level
  • LEXX $0.86
  • BWEN $1.77
  • Resistance Level
  • LEXX $1.05
  • BWEN $1.96
  • Average True Range (ATR)
  • LEXX 0.05
  • BWEN 0.08
  • MACD
  • LEXX 0.00
  • BWEN 0.01
  • Stochastic Oscillator
  • LEXX 0.14
  • BWEN 92.86

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: